Matt Kaeberlein, a longevity researcher and CEO of Optispan, had symptoms of low testosterone. He got his levels tested in his 50s and gradually began testosterone replacement therapy (TRT). He said ...
While TRT is only U.S. Food and Drug Administration (FDA)approved for men with clinically low testosterone levels, marketing has expanded TRT’s reach to those seeking enhanced vitality, from increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results